Head of the Bavarian State Chancellery Honors Entrepreneurial Achievements PLANEGG, MUNICH, GERMANY / ACCESSWIRE / July 6, 2017 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC PINK: MPSYY, XETRA: MOR), one of the premier biotechnology companies in Germany, is celebrating its 25 th company anniversary today. At a ceremony with approximately 500 guests from business and politics, as well as employees of the Munich/Germany-based antibody-based drug developer, Dr. Marcel Huber, Head of the State Chancellery of the Government of the Federal State of Bavaria, honored the successful development of the company. He stated, "MorphoSys was one of the first companies located in Planegg-Martinsried, which has established leading-edge research for